-
ILLUMINA INC NASDAQ:ILMN Illumina is improving human health by unlocking the power of the genome. Its focus on innovation has established it as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The Company products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
Location: 5200 Illumina Way, California, 92122-4616, US | Website: www.illumina.com | Industry: Analytical Laboratory Instrument Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
24.23B
Cash
994M
Avg Qtr Burn
N/A
Short % of Float
3.46%
Insider Ownership
0.27%
Institutional Own.
93.18%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|